DrugDashboards

Shiseido Benefiance Wrinkle Smoothing Day

AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE · AVOBENZONE 1032 mg/50mL; HOMOSALATE 2580 mg/50mL; OCTINOXATE 3818 mg/50mL; OCTOCRYLENE 1548 mg/50mL; OXYBENZONE 774 mg/50mL · Cream · Topical · Shiseido Americas Corporation

NDC 58411-0439-50 · 1 JAR in 1 CARTON / 50 mL in 1 JAR · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
M020
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE (Cream)

LabelerStrengthFirst seenLast seen
Shiseido Americas CorporationAVOBENZONE 1032 mg/50mL; HOMOSALATE 2580 mg/50mL; OCTINOXATE 3818 mg/50mL; OCTOCRYLENE 1548 mg/50mL; OXYBENZONE 774 mg/50mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Shiseido Benefiance Wrinkle Smoothing Day — NDC 58411-0439-50," retrieved September 3, 2026, https://drugdashboards.com/drug/58411043950.

Free to cite with attribution — see how the data is put together.